InvestorsHub Logo

nidan7500

03/20/19 10:59 AM

#185917 RE: nidan7500 #185909

Another priceless bit of leadership strategy here w/organizing ERP science for CNS disease trials processing. Considering the obvious confusion and lack of leadership @FDA and also considering the cost and importance of effective CNS disease treatment, WOW is right. This is a brilliant strategic move. BTW, AVXL has a partnership/type patent APP underway with the ERP leading manufacturer. Musashi would be proud, much more to follow on this IMO.

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220180360796%22.PGNR.&OS=DN/20180360796&RS=DN/20180360796